Skip to content

A study to compare homoeopathic treatment given with the help of Artificial Intelligence and by traditional methods

Comparative Clinical Evaluation of Artificial-Intelligence & Neural Language-Models Assisted Prescription versus Conventional Repertory based Prescription in Homoeopathy Assessing Improvement in Patient Reported Outcomes: Single-Blind, Randomized, Exploratory, Pilot Study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096059
Enrollment
362
Registered
2025-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: AI-NLMs assisted Prescription: After fulfilling inclusion criteria and getting written consent, case taking will be done on a case recording format, which format will be same for both g

Sponsors

Metropolitan Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex, 18-65 years of age. 2. Patients seeking homoeopathic treatment. 3. Willingness to participate and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with immediate surgical emergency. 2. Self-declared and/or diagnosed severe uncontrolled systemic diseases such as advanced stage of malignancy, renal failure, decompensated cardiac disease and immune-compromised states. 3. Pregnant and lactating mother. 4. Patients requiring immediate conventional intervention. 5. Patient already under-goes homoeopathy treatment any illness. 6. Patients unwilling or unable to complete follow-up. 7. Patient with unstable mental condition.

Design outcomes

Primary

MeasureTime frame
Outcome in Relation to Impact on Daily Living (ORIDL)Timepoint: Baseline, After 4 weeks, After 8 weeks

Secondary

MeasureTime frame
EuroQol Visual Analogue Scale (EQ-VAS)Timepoint: Baseline, After 4 weeks, After 8 weeks;Patient Global Impression of Change (PGIC)Timepoint: Baseline, After 4 weeks, After 8 weeks;Time taken for remedy selection (recorded in seconds by stopwatches)Timepoint: Baseline

Countries

India

Contacts

Public ContactDebarsi Das

Metropolitan Homoeopathic Medical College and Hospital

avidipta.kurchi@gmail.com6295628901

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026